CalciMedica CFO Stephen Bardin to resign following Q3 2026 10-Q filing
On October 15, 2026, Stephen Bardin, CalciMedica's Chief Financial Officer, principal accounting officer, and principal financial officer, provided notice of his resignation. The resignation will become effective immediately following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Mr. Bardin is leaving to pursue another professional opportunity, and the Company stated his resignation was not due to any disagreement with the Company.
Key takeaways
CFO departure: Stephen Bardin provided notice of his resignation on October 15, 2026.
Roles held: Mr. Bardin served as Chief Financial Officer, principal accounting officer, and principal financial officer of CalciMedica.
Effective date: The resignation will become effective immediately following the filing of the Form 10-Q for the quarter ended September 30, 2026.
Stated reason: Mr. Bardin is leaving to pursue another professional opportunity.
No disagreement: The Company stated that Mr. Bardin's resignation was not due to any disagreement with the Company.
Filing officer: The 8-K was signed by A. Rachel Leheny, Ph.D., Chief Executive Officer.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow CALC in real time
Get material earnings, filing, IR, and earnings-call alerts by email.